MARINUS PHARMACEUTICALS, INC. Quarterly Operating Income (Loss) in USD from Q2 2013 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Marinus Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2013 to Q3 2024.
  • Marinus Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$21.1M, a 33.4% increase year-over-year.
  • Marinus Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$125M, a 0.55% increase year-over-year.
  • Marinus Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$131M, a 16.6% decline from 2022.
  • Marinus Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$113M, a 16.4% decline from 2021.
  • Marinus Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$96.9M, a 42.7% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$125M -$21.1M +$10.6M +33.4% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 -$135M -$32.2M -$797K -2.54% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 -$134M -$35.8M -$2.86M -8.67% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 -$131M -$35.4M -$6.23M -21.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-05
Q3 2023 -$125M -$31.6M -$1.55M -5.14% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$124M -$31.4M +$5.33M +14.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$129M -$33M -$16.3M -97.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 -$113M -$29.2M -$2.1M -7.73% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-05
Q3 2022 -$111M -$30.1M -$10.9M -57% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 -$99.8M -$36.8M -$13.3M -56.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$86.5M -$16.7M +$10.5M +38.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$96.9M -$27.1M -$9.61M -54.9% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-09
Q3 2021 -$87.3M -$19.2M -$3.47M -22.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 -$83.8M -$23.5M -$7.6M -47.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$76.2M -$27.2M -$8.31M -44.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$67.9M -$17.5M -$2.03M -13.1% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-24
Q3 2020 -$65.9M -$15.7M -$1.8M -13% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 -$64.1M -$15.9M -$3.37M -26.9% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q1 2020 -$60.7M -$18.9M -$6.32M -50.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 -$54.4M -$15.5M -$5.2M -50.6% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-09
Q3 2019 -$49.2M -$13.9M -$2.68M -23.9% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$46.5M -$12.5M -$2.94M -30.7% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 -$43.6M -$12.5M -$6.43M -105% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-04
Q4 2018 -$37.2M -$10.3M -$5.34M -108% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-16
Q3 2018 -$31.8M -$11.2M -$7.01M -166% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 -$24.8M -$9.57M -$5.06M -112% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 -$19.8M -$6.11M -$729K -13.5% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-01
Q4 2017 -$19M -$4.94M +$994K +16.8% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-12
Q3 2017 -$20M -$4.21M +$2.16M +33.9% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-29
Q2 2017 -$22.2M -$4.51M +$4.34M +49% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-03
Q1 2017 -$26.5M -$5.39M +$1.71M +24.1% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-02
Q4 2016 -$28.2M -$5.93M +$1.57M +20.9% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-12
Q3 2016 -$29.8M -$6.37M -$1.52M -31.3% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-31
Q2 2016 -$28.3M -$8.84M -$3.67M -71.1% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-01
Q1 2016 -$24.6M -$7.1M -$183K -2.65% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-01
Q4 2015 -$24.4M -$7.5M -$3.94M -111% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-07
Q3 2015 -$20.5M -$4.85M -$2.41M -99% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-08
Q2 2015 -$18.1M -$5.17M -$1.91M -58.4% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 -$16.2M -$6.92M -$4.25M -159% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-02
Q4 2014 -$11.9M -$3.56M Oct 1, 2014 Dec 31, 2014 10-K 2017-03-13
Q3 2014 -$2.44M -$1.12M -84.4% Jul 1, 2014 Sep 30, 2014 10-Q 2015-10-29
Q2 2014 -$3.26M -$1.62M -98.9% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-04
Q1 2014 -$2.67M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q3 2013 -$1.32M Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-13
Q2 2013 -$1.64M Apr 1, 2013 Jun 30, 2013 10-Q/A 2014-10-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.